Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,682.40
(
-0.09%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
92.71
(
-3.40%
)
Bitcoin
69,358.14
(
-2.82%
)
News Focus
News Focus
Post# of 15281
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 934
Posts 159931
Boards Moderated 2
Alias Born 08/13/2010

BottomBounce

Member Level

Re: JsTrades post# 15232

Friday, 05/14/2021 6:11:32 AM

Friday, May 14, 2021 6:11:32 AM

Post# of 15281
$IBIO iBio on May 6 disclosed the development of IBIO-202. “In light of the successful global roll-out of COVID-19 vaccines targeting the S protein and the emergence of variant strains of the disease, we decided to focus our efforts on the continued development of IBIO-202 as a differentiated vaccine candidate,” stated Tom Isett, iBio’s chairman and CEO. https://www.genengnews.com/covid-19-candidates/ibio-ibio-202/

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today